Genetic biomarkers for ALS disease in transgenic SOD1 G93A mice

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Calvo, Ana C ^a   Manzano, Raquel ^a   Atencia Cibreiro, Gabriela ^b   Oliván, Sara ^a   Muñoz, María J ^a   Zaragoza, Pilar ^a   Cordero Vázquez, Pilar ^b   Esteban Pérez, Jesús ^b   García Redondo, Alberto ^b   Osta, Rosario ^a  

^a UNIVERSIDAD DE ZARAGOZA   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANKRD1 PROTEIN; ATROGIN 1; CALM1 PROTEIN; COL19A1 PROTEIN; GSR PROTEIN; IMPA1 PROTEIN; MEF2C PROTEIN; MT2 PROTEIN; MYOD1 PROTEIN; MYOG PROTEIN; MYOGENIC FACTOR 5; NNT PROTEIN; PROTEIN; PROTEIN NOGO A; RNA; RRAD PROTEIN; SLN PROTEIN; SNX10 PROTEIN; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR PAX7; UNCLASSIFIED DRUG; COPPER ZINC SUPEROXIDE DISMUTASE; MUTANT PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKRD1 GENE; ARTICLE; CALM1 GENE; COL19A1 GENE; CONTROLLED STUDY; DISEASE COURSE; FBXO32 GENE; FEMALE; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GSR GENE; IMPA1 GENE; LONGEVITY; MALE; MEF2C GENE; MOUSE; MT2 GENE; MUSCLE BIOPSY; MYF5 GENE; MYOD1 GENE; MYOG GENE; NNT GENE; NOGO A GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PAX7 GENE; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; RRAD GENE; SKELETAL MUSCLE; SLN GENE; SNX10 GENE; TRANSGENIC MOUSE; ANIMAL; BIOPSY; DENERVATION; DISEASE MODEL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC MARKER; GENETICS; HUMAN; METABOLISM; PATHOLOGY;

ANIMALIA; MUS;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BIOPSY; DENERVATION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC MARKERS; HUMANS; LONGEVITY; MALE; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; MUTANT PROTEINS; SUPEROXIDE DISMUTASE; TRANSCRIPTION, GENETIC;

EID: 84857839750     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032632     Document Type: Article

References (64)

1. Azuaje F, (2010) Bioinformatics and Biomarker Discovery. "Omic" data analysis for personalized medicine West Sussex, UK Wiley-Blackwell.
2. Siddique N, Siddique T, (2008) Genetics of Amyotrophic Lateral Sclerosis. Phys Med Rehabil Clin N Am 19: 429-vii doi:10.1016/j.pmr.2008.05.001.
3. Hensley K, Mhatre M, Mou S, Pye QN, Stewart C, et al. (2006) On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Antioxid. Redox. Signal 8: 2075-2087.
4. Cluskey S, Ramsden DB, (2001) Mechanism of neurodegeneration in amyotrophic lateral sclerosis. J Clin Pathol pp. 54.
5. Bruijn LI, Houseweart MK, Kato S, Anderson KL, Anderson SD, et al. (1998) Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281: 1851-1854.
6. Wijesekera LC, Leigh PN, (2009) Amyotrophic Lateral Sclerosis. Orph J Rare Dis 4: 3 doi:10.1186/1750-1172-4-3.
7. Baek WS, Desai NP, (2007) ALS: pitfalls in the diagnosis. Pract Neurol 7: 74-81.
8. Turner MR, Kiernan MC, Nigel P, et al. (2009) Biomarkers in amyotrophic lateral sclerosis. The Lancet 8: 94-109.
9. Kwiatkowski TJJ, Bosco DA, LeClerc AL, Tamrazian E, Vanderburg CR, et al. (2009) Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis. Science 323: 1205-1208.
10. Vance C, Rogelj B, Hortobágyi T, De Vos KJ, Nishimura AL, et al. (2009) Mutations in FUS, an RNA processing protein, cause Familial Amyotrophic Lateral Sclerosis type 6. Science 323: 1208-1211.
11. Deng HX, Zhai H, Bigio EH, Yan J, Fecto F, et al. (2010) FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann Neurol 67: 739-748.
12. Liscic RM, Grinberg LT, Zidar J, Gitcho MA, Cairns NJ, (2008) ALS and FTLD: two faces of TDP-43 proteinopathy. European Journal of Neurology 15: 772-780.
13. Lagier-Tourenne C, Cleveland DW, (2009) Rethinking ALS: The FUS about TDP-43. Cell 136: 1001-1004.
14. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264: 1772-1775.
15. Sumiyoshi H, Mor N, Lee SY, Doty S, Henderson S, et al. (2004) Esophageal muscle physiology and morphogenesis require assembly of a collagen XIX-rich basement membrane zone. J Cell Biol 166: 591-600.
16. Mitsumoto H, Santella RM, Liu X, Bogdanov M, Zipprich J, et al. (2008) Oxidative stress biomarkers in sporadic ALS. Amyotrophic Lateral Sclerosis 9: 177-183.
17. Ryberg H, Bowser R, (2008) Protein biomarkers for amyotrophic lateral sclerosis. Expert Rev Proteomics 5: 249-262.
18. Turner MR, Kiernan MC, Leigh PN, Talbot K, (2009) Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol 8: 94-109.
19. Pradat PF, Dib M, (2009) Biomarkers in amyotrophic lateral sclerosis: facts and future horizons. Mol Diagn Ther 13: 115-125.
20. Pradat PF, (2009) New biological and radiological markers in amyotrophic lateral sclerosis. Presse Med 38: 1843-1851.
21. Wijesekera LC, Leigh PN, (2009) Amyotrophic lateral sclerosis. Orph J Rare Dis 4: 3 doi:10.1186/1750-1172-4-3.
22. Musaró A, (2010) State of the art and the dark side of amyotrophic lateral sclerosis. World J Biol Chem 1: 62-68.
23. de Carvalho M, Swash M, (2011) Amyotrophic lateral sclerosis: an update. Curr Opin Neurol 24 (5): 497-503.
24. Douglass CP, Kandler RH, Shaw PJ, (2010) An evaluation of neurophysiological criteria used in the diagnosis of motor neuron disease. J Neurol Neurosurg Psychiatry 81: 646-649.
25. Burgunder JM, Schöls L, Baets J, Andersen P, Gasser T, et al. (2011) EFNS guidelines for the molecular diagnosis of neurogenetic disorders: motoneuron, peripheral nerve and muscle disorders. Eur J Neurol 18 (2): 207-217 doi:10.1111/j.1468-1331.2010.03069.x.
26. Dobrowolny G, Aucello M, Rizzuto E, Beccafico S, Mammucari C, et al. (2008) Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metabolism 8: 425-436.
27. Dupuis L, Loeffler JP, (2008) Sclérose latérale amyotrophique, junction neuromusculaire et _raline énergétique. Medecine/Sciences 24: 1077-1082.
28. Babu GP, Bhupathy P, Timofeyev V, Petrashevskaya NN, Reiser PJ, et al. (2007) Ablation of sarcolipin enhances sarcoplasmic reticulum calcium transport and atrial contractility. PNAS 104: 17867-17872.
29. Sumiyoshi H, Mor N, Lee SY, Doty S, Henderson S, et al. (2004) Esophageal muscle physiology and morphogenesis require assembly of a collagen XIX-rich basement membrane zone. J Cell Biol 166: 591-600.
30. Manzano R, Toivonen JM, Oliván S, Calvo AC, Moreno-Igoa M, et al. (2011) Altered Expression of Myogenic Regulatory Factors in the Mouse Model of Amyotrophic Lateral Sclerosis. Neurodegenerative Dis 8 (5): 386-396 doi:10.1159/000324159.
31. Dupuis L, González de Aguilar JL, di Scala F, Rene F, de Tapia M, et al. (2002) Nogo provides a molecular marker for diagnosis of Amyotrophic Lateral Sclerosis. Neurobiol Dis 10: 358-365.
32. Jokic N, González de Aguilar JL, Dimou L, Lin S, Fergani A, (2006) EMBO Reports 7: 1162-1167 doi:10.1038/sj.embor.7400826.
33. Nakamura K, Nakada C, Takeuchi K, Osaka M, Shomori K, et al. (2002-2003) Altered expression of cardiac ankyrin repeat protein and its homologue, ankyrin repeat protein with PEST and proline-rich region, in atrophic muscles in amyotrophic lateral sclerosis. Pathobiology 70: 197-203.
34. Léger B, Vergani L, Sorarù G, Hespel P, Derawe W, et al. (2006) Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. The FASEB J 20: 583-585 doi 10.1096/fj.05-5249fje.
35. Qin B, He M, Chen X, Pei D, (2006) Sorting nexin 10 induces giant vacuoles in mammalian cells. J Biol Chem 281: 36891-36896.
36. Berggård T, Szczepankiewicz O, Thulin E, Linse S, (2002) Myo-inositol monophosphatase is an activated target of calbindin D28k. J Biol Chem 277: 41954-41959.
37. Freeman HC, Hugill A, Dear NT, Ashcroft FM, Cox RD, (2006) Deletion of nicotinamide nucleotide transhydrogenase: A new quantitive trait locus accounting for glucose intolerance in C57BL/6J mice. Diabetes 55: 2153-2156.
38. Halter B, Gonzalez de Aguilar JL, Rene F, Petri S, Fricker B, et al. (2010) Oxidative stress in skeletal muscle stimulates early expression of Rad in a mouse model of amyotrophic lateral sclerosis. Free Rad Biol Med 48: 915-923.
39. Dudley RWR, Khairallah M, Mohammed S, Lands L, Des Rosiers C, et al. (2006) Dynamic responses of the glutathione system to acute oxidative stress in dystrophic mouse (mdx) muscles. Am J Physiol Regul Integr Comp Physiol 291: R704-R710.
40. Léger B, Sense R, Al-Khodairy AW, Dériaz O, Gobelet C, et al. (2009) Atrogin-1, murf1, and foxo, as well as phosphorylated gsk-3β and 4e-bp1 are reduced in skeletal muscle of chronic spinal cord-injured patients. Muscle & Nerve 40: 69-78.
41. Borselli C, Storrie H, Benesch-Lee F, Shvartsman D, Cezar C, (2010) Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. PNAS 107: 3287-3292.
42. Sakuma K, Yamaguchi A, (2010) The functional role of calcineurin in hypertrophy, regeneration, and disorders of skeletal muscle. J Biomed Biotech doi:10.1155/2010/721219.
43. Vasu VT, Ott S, Hobson B, Rashidi V, Oommen S, et al. (2009) Sarcolipin and ubiquitin carboxy-terminal hydrolase 1 mRNAs are over-expressed in skeletal muscles of α-tocopherol deficient mice. Free Radic Res 43: 106-116.
44. Magnusson C, Svensson A, Christerson U, Tågerud S, (2005) Denervation-induced alterations in gene expression in mouse skeletal muscle. Eur J Neurosci 21: 577-580 doi:10.1111/j.1460-9568.2005.03855.x.
45. Limon-Pacheco JH, Gonsebatt ME, (2010) The glutathione system and its regulation by neurohormone melatonin in the central nervous system. Cent Nerv Syst Agents Med Chem 10: 287-297.
46. Gonzalez de Aguilar JL, Niederhauser-Wiederkehr C, Halter B, de Tapia M, di Scala F, et al. (2008) Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model. Physiol Genomics 32: 207-218.
47. Laure L, Suel L, Roudaut C, Bourg N, Ouali A, et al. (2009) Cardiac ankyrin repeat protein is a marker of skeletal muscle pathological remodelling. FEBS J 276: 669-684.
48. Fergani A, Dupuis L, Jokic N, Larmet Y, de Tapia M, et al. (2005) Reticulons as markers of neurological diseases: focus on amyotrophic lateral sclerosis. Neurodegen Dis 2: 185-194.
49. Pradat PF, Bruneteau G, Gonzalez de Aguilar JL, Dupuis L, Jokic N, et al. (2007) Muscle Nogo-A expression is a prognostic marker in lower motor neuron syndromes. Ann Neurol 62: 15-20.
50. Yan R, Shi Q, Hu X, Zhou X, (2006) Reticulon proteins: emerging players in neurodegenerative diseases. Cell Mol Life Sci 63: 877-889.
51. Lagirand-Cantaloube J, Cornille K, Csibi A, Batonnet-Pichon S, Leibovitch MP, et al. (2009) Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo. PLos One 4: e4973.
52. Dupuis L, Loeffler JP, (2009) Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic mice. Curr Op Pharm 9: 341-346.
53. Ilany J, Bilan PJ, Kapur S, Caldwell JS, Patti ME, et al. (2006) Overexpression of Rad in muscle worsens diet-induced insulin resistance and glucose intolerance and lowers plasma triglyceride level. PNAS 103: 4481-4486.
54. Wu XS, McNeil BD, Xu J, Fan J, Xue L, et al. (2009) Ca2+ and calmodulin initiate all forms of endocytosis during depolarization at a nerve terminal. Nat Neurosci 12: 1003-1010.
55. DeRuisseau LR, Recca DM, Mogle JA, Zoccolillo M, DeRuisseau KC, (2009) Metallothionein deficiency leads to soleus muscle contractile dysfunction following acute spinal cord injury in mice. Am J Physiol Regul Integr Comp Physiol 297: R1795-R1802.
56. White RB, Ziman MR, (2008) Genome-wide discovery of Pax7 target genes during development. Physiol Genomics 33: 41-49.
57. Zhao P, Caretti G, Mitchell S, McKeehan WL, Boskey AL, et al. (2006) Fgfr4 is required for effective muscle regeneration in vivo: Delineation of a MyoD-Tead2-Fgfr4 transcriptional pathway. J Biol Chem 281: 429-438.
58. Gayraud-Morel B, Chrétien F, Flamant P, Gomès D, Zammit PS, et al. (2007) A role for the myogenic determination gene Myf5 in adult regenerative myogenesis. Develop Biol 312: 13-28.
59. Dodou E, Xu SM, Black BL, (2003) Mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo. Mechanism Develop 120: 1021-1032.
60. Cao Y, Kumar RM, Penn BH, Berkes CA, Kooperberg C, et al. (2006) Global and gene-specific analyses show distinct roles for Myod and Myog at a common set of promoters. The EMBO J 25: 502-511.
61. Murillo S, Calvo AC, Osta R, et al. (2009) Biopsia muscular en ratón. National Congress of the Spanish Society for the Sciences of the Laboratory Animals. Salamanca.
62. Ludolph A, Bendotti C, Blaugrund E, Chio A, Greensmith L, et al. (2010) Guidelines for preclinical animal research in ALS/MND: A consensus meeting. Amyotrophic Lateral Sclerosis 11: 38-45.
63. Leitner M, Menzies S, Lutz C, (2010) Working with ALS Mice. Guidelines for preclinical testing & colony management Cambridge and Maine Prize4Life and The Jackson Laboratory pp. 1-21.
64. Calvo AC, Moreno-Igoa M, Manzano R, Ordovás L, Yagüe G, et al. (2008) Determination of protein and RNA expression levels of common housekeeping genes in a mouse model of neurodegeneration. Proteomics 8: 4338-4343.